Yu Shimizu

Yu Shimizu is an accomplished professional with a strong background in Economics, having studied at Tokyo Metropolitan University.

Over the years, Yu has gained extensive experience in the pharmaceutical industry, particularly at Novartis, where he held various key positions.

Currently, Yu Shimizu serves as the Global Finance Head for the Ophtha Franchise at Novartis, showcasing his strategic financial acumen and leadership skills.

Prior to his current role, Yu Shimizu successfully fulfilled responsibilities such as serving as the Philippines Country CFO, a.i. Japan Oncology Business Unit General Manager, Japan Oncology Business Unit Finance Head, Japan Development Finance Head, Global Pharma Business Planning and Analysis Senior Financial Analyst, and Japan Pharma Division Business Planning and Analysis Senior Analyst at Novartis.

Before his tenure at Novartis, Yu Shimizu also held notable positions including Vice President at Atsushi Information Company, Associate at Deutsche Bank, and Senior Analyst at ITOCHU Corporation.

Yu Shimizu's diverse professional journey has equipped him with a multifaceted skill set and an in-depth understanding of finance, business planning, and analysis across various industries.